A recent study has determined that Finzelberg's functional ingredient, CONCENTAL, could improve symptoms of anxiety by up to 19% in menopausal individuals.
The experiment, which was run for a 28-day period, tested the benefits of the Greek mountain tea extract in managing menopause-related anxiety in women aged between 50 to 70 years old.
With a 475mg dose of the nutraceutical, there was a significant improvement in anxiety symptoms in patients aged 50–60 years old, with a similar trend seen in those older than 60.
In this study, the over 60s experienced a reduction in anxiety of up to 12%, explained Dr Cynthia Suarez-Rizzo, the Project Manager of New Product Development at Finzelberg:
"CONCENTAL exhibited significant improvements compared to placebo in the 50–60 age range with a 475mg dose. In the over 60s, we noticed that a higher dosage seems to be more effective."
"While the age of the women and/or the period of menopause could influence the level of anxiety, different concentrations may provide benefits to these two groups in particular."
The consumer desire for natural, non-stimulant alternatives
Currently, there is an unmet need for those going through the menopause, as there is a lack of non-stimulating, natural and plant-based functional ingredients that target cognitive health in this space.
Because of this, Finzelberg developed CONCENTAL to provide a nutraceutical that can offer comprehensive cognitive support, while also not exhibiting any addictive properties.
According to the functional ingredients provider, CONCENTAL can be used in a wide range of supplement applications, including powders, tablets, gummies and shots.
“Hormonal changes experienced during menopause could have a direct impact on the body’s nervous system, which could lead to a series of physical manifestations,” Dr Cynthia Suarez-Rizzo, project manager, of new product development at Finzelberg explains. “This is because the chemical processes that occur in the reproductive system and the brain affect mood, predisposing women to feelings of nervousness, tension, or worry.”
For those wanting more information on the study and its implications, a whitepaper discussing it is available on the company's website.
Dr Suarez-Rizzo added: “Hormonal changes experienced during menopause could have a direct impact on the body’s nervous system, which could lead to a series of physical manifestations,”
“This is because the chemical processes that occur in the reproductive system and the brain affect mood, predisposing women to feelings of nervousness, tension, or worry. Therefore, cognition-targeting nutraceuticals such as CONCENTAL could offer as a great solution for those struggling with their symptoms.”
Reference
1 https://researchportal.northumbria.ac.uk/en/publications/the-acute-and-chronic-cognitive-and-cerebral-blood-flow-effects-o-2